
This study discusses the current understanding of allergic fungal rhinosinusitis (AFRS), a subtype of chronic rhinosinusitis (CRS) with nasal polyps. The study highlights recent developments in understanding the dysregulated molecular pathways that contribute to AFRS, including the role of fungi-driven respiratory inflammation and an exaggerated type 2 inflammatory response. These findings have led to identifying potential novel therapeutic targets and transitioning away from long oral corticosteroid courses in managing AFRS. The study suggests that a better understanding of fungi-driven inflammatory pathways may have broader implications for understanding CRS inflammation.
Like
Save
Share